Venture studioAVB Invest is a global venture studio based in New York that focuses on creating next-generation businesses through technology and innovation. It employs a data-driven management approach to support sustainable and inclusive growth.

Autobahn Labs, Inc. is a Palo Alto-based virtual drug discovery incubator that partners with academic institutions to co-found biotech companies. It focuses on transforming early-stage research into preclinical drug candidates by providing funding and expertise.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Autobahn Labs, Inc. is an organization focused on accelerating early-stage drug discovery and development. Founded by Samsara BioCapital and Charles River Laboratories, it partners with academic institutions and scientists to identify promising early-stage research projects that can lead to new therapies for patients. Autobahn Labs aims to transform scientific discoveries into medicines by providing expertise, resources, and funding.
Autobahn Labs invests in early-stage scientific research with the goal of developing preclinical drug candidates. The organization collaborates with academic institutions to identify novel concepts that may not otherwise receive adequate resources. They provide seed funding, operational expertise, and industrialized drug discovery capabilities to advance projects from target validation to preclinical development.
Autobahn Labs offers funding of up to $5 million per project, operational expertise, and access to industrialized drug discovery capabilities to advance scientific projects to preclinical drug candidates.
Autobahn Labs focuses on early-stage scientific research, particularly in biotech and healthcare sectors. They seek projects that can develop into preclinical drug candidates and prioritize collaborations with academic institutions.
Founders can pitch their startups by visiting the contact page on Autobahn Labs' website at autobahn-labs.com/contact. It is advisable to include a detailed overview of the project, including scientific validation and potential therapeutic applications.
Autobahn Labs differentiates itself by providing not only funding but also operational expertise and industrialized drug discovery capabilities. Their partnerships with leading academic institutions enhance their ability to identify and support innovative research.
Autobahn Labs typically invests between $1 million and $5 million per project, focusing on advancing early-stage research to preclinical development.
Autobahn Labs operates globally, seeking innovative projects from various regions that align with their investment focus in biotech and healthcare.
Post-investment, Autobahn Labs offers operational support and expertise to help advance projects through the drug development process, leveraging their partnerships and resources.
Superscout Pro
Is this page right?Reviewed · How the research works